S-allyl cysteine mitigates oxidative damage and improves neurologic deficit in a rat model of focal cerebral ischemia

Nutrition Research

Volumn 32, Issue 2, 2012, Pages 133-143

  Ashafaq, Mohammad ^a   Khan, Mohd Moshahid ^a,b   Shadab Raza, Syed ^a   Ahmad, Ajmal ^a,c   Khuwaja, Gulrana ^a   Javed, Hayate ^a   Khan, Andleeb ^a   Islam, Farah ^d   Siddiqui, M Saeed ^a   Safhi, Mohammed M ^e   Islam, Fakhrul ^a,e  

^a HAMDARD UNIVERSITY   (India)

^b UNIVERSITY OF IOWA   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d HAMDARD UNIVERSITY   (India)

^e JAZAN UNIVERSITY   (Saudi Arabia)

Author keywords

Inflammation; Middle cerebral artery occlusion; Neurobehavior; Oxidative damage; S allyl cysteine

Indexed keywords

CATALASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; INDUCIBLE NITRIC OXIDE SYNTHASE; S ALLYLCYSTEINE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FRONTAL CORTEX; GRIP STRENGTH; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ROTAROD TEST; UPREGULATION;

ALLIUM; ANIMALS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; BRAIN ISCHEMIA; CEREBRUM; CYSTEINE; GLIAL FIBRILLARY ACIDIC PROTEIN; INFARCTION, MIDDLE CEREBRAL ARTERY; INFLAMMATION; MALE; NERVOUS SYSTEM DISEASES; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 84863408335     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2011.12.014     Document Type: Article

References (53)

1. Shah M.K., Shin W., Parikh V.S., Ragin A., Mouannes J., Bernstein R.A., et al. Quantitative cerebral MR perfusion imaging: preliminary results in stroke. J Magn Reson Imaging 2010, 32:796-802.
2. Khan M.M., Ishrat T., Ahmad A., Hoda M.N., Khan M.B., Khuwaja G., et al. Sesamin attenuates behavioral, biochemical and histological alterations induced by reversible middle cerebral artery occlusion in the rats. Chem Biol Interact 2010, 183:255-263.
3. Chen H., Hong H., Liu D., Xu G., Wang Y., Zeng J., et al. Lesion patterns and mechanism of cerebral infarction caused by severe atherosclerotic intracranial internal carotid artery stenosis. J Neurol Sci 2011, 307:79-85.
4. Allen C.L., Bayraktutan U. Oxidative stress and its role in the pathogenesis of ischaemic stroke. Stroke 2009, 4:461-470.
5. Niizuma K., Endo H., Chan P.H. Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J Neurochem 2009, 109:133-138.
6. Loh K.P., Qi J., Tan B.K., Liu X.H., Wei B.G., Zhu Y.Z. Leonurine protects middle cerebral artery occluded rats through antioxidant effect and regulation of mitochondrial function. Stroke 2010, 41:2661-2668.
7. Sun M., Zhao Y., Gu Y., Xu Y. Inhibition of nNOS reduces ischemic cell death through down-regulating calpain and caspase-3 after experimental stroke. Neurochem Int 2009, 54:339-346.
8. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
9. Takano K., Tatlisumak Y., Bergmann A.G., Gibson D.G., Fisher M. Reproducibility and reliability of middle cerebral artery occlusion using a silicone-coated suture (Koizumi) in rats. J Neurol Sci 1997, 153:8-11.
10. Khan M.M., Ahmad A., Ishrat T., Khuwaja G., Srivastava P., Khan M.B., Islam F. Rutin protects the neural damage induced by transient focal ischemia in rats. Brain Res 2009, 1292:123-135.
11. Maldonado P.D., Barrera D., Rivero I., Mata R., Medina-Campos O.N., Hernández-Pando R., et al. Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage. Free Radic Biol Med 2003, 35:317-324.
12. Pérez-Severiano F, Rodríguez-Pérez M, Pedraza-Chaverrí J, Maldonado PD, Medina-Campos ON, Ortíz-Plata A, Sánchez-García A, Villeda-Hernández J, Galván-Arzate S, Aguilera.
13. Garcia E., Limon D., Perez-De V., La Cruz L.a., Giordano M., Diaz-Muñoz M., et al. Lipid peroxidation, mitochondrial dysfunction and neurochemical and behavioural deficits in different neurotoxic models: protective role of S-allylcysteine. Free Radic Res 2008, 42:892-902.
14. Rojas P., Serrano-García N., Medina-Campos O.N., Pedraza-Chaverri J., Maldonado P.D., Ruiz-Sánchez E. S-allylcysteine, a garlic compound, protects against oxidative stress in 1-methyl-4-phenylpyridinium-induced parkinsonism in mice. J Nutr Biochem 2010, [Epub ahead of print].
15. Kim J.M., Chang N., Kim W.K., Chun H.S. Dietary S-allyl-L-cysteine reduces mortality with decreased incidence of stroke and behavioral changes in stroke-prone spontaneously hypertensive rats. Biosci Biotechnol Biochem 2006, 70:1969-1971.
16. Atif F., Yousuf S., Agrawal S.K. S-allyl l-cysteine diminishes cerebral ischemia-induced mitochondrial dysfunctions in hippocampus. Brain Res 2009, 1265:128-137.
17. Pérez-Severiano F., Salvatierra-Sánchez R., Rodríguez-Pérez M., Cuevas-Martínez E.Y., Guevara J., Limón D., et al. S-allylcysteine prevents amyloid-beta peptide-induced oxidative stress in rat hippocampus and ameliorates learning deficits. Eur J Pharmacol 2004, 489:197-202.
18. Javed H., Khan M.M., Khan A., Vaibhav K., Ahmad A., Khuwaja G., et al. S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Res 2011, 1389:133-142.
19. García E., Villeda-Hernández J., Pedraza-Chaverrí J., Maldonado P.D., Santamaría A. S-allylcysteine reduces the MPTP-induced striatal cell damage via inhibition of pro-inflammatory cytokine tumor necrosis factor-α and inducible nitric oxide synthase expressions in mice. Phytomedicine 2010, 18:65-73.
20. Numagami Y., Sato S., Ohnishi S.T. Attenuation of rat ischemic brain damage by aged garlic extracts: a possible protecting mechanism as antioxidants. Neurochem Int 1996, 29:135-143.
21. Masuo Y., Matsumoto Y., Morita S., Noguchi J. A novel method for counting spontaneous motor activity in the rat. Brain Res Brain Res Protoc 1997, 1:321-326.
22. Moran P.M., Higgins L.S., Cordel B., Moser P.C. Age related learning deficits in transgenic mice expressing the 721- amino acid isoform of human beta-amyloid precursor protein. Proc Natl Acad Sci USA 1995, 92:5341-5345.
23. Utley H.C., Bernhein F., Hochslein P. Effects of sulfhydryl reagent on peroxidation in microsomes. Arch Biochem Biophys 1967, 260:521-531.
24. Jollow D.J., Mitchell J.R., Zampaghone N., Gillete J.R. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic intermediate. Pharmacology 1974, 11:161-169.
25. Carlberg I., Mannerviek B. Glutathione reductase levels in rat brain. J Biol Chem 1975, 250:5475-5480.
26. Mohandas J., Marshall J.J., Duggin G.G., Horvath J.S., Tiller D. Differential distribution of glutathione and glutathione related enzymes in rabbit kidneys: possible implication in analgesic neuropathy. Cancer Res 1984, 44:5086-5091.
27. Stevens M., Obrosova I., Cao X., Huysen C.V., Green D.A. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism and oxidative stress in experimental diabetic neuropathy. Diabetes 2000, 49:1006-1015.
28. Claiborne A. Catalase activity. CRC Hand Book of Methods For Oxygen Radical Research 1985, 283-284. CRC Press, Boca Raton, FL. R.A. Green Wald (Ed.).
29. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem 1951, 193:265-275.
30. Saleem S., Ahmad M., Ahmad A.S., Yousuf S., Ansari M.A., Khan M.B., et al. Effect of saffron (Crocus sativus) on neurobehavioral and neurochemical changes in cerebral ischemia in rats. J Med Food 2006, 9:246-253.
31. Schwarting R.K., Bonatz A.E., Carey R.J., Huston J.P. Relationships between indices of behavioral asymmetries and neurochemical changes following mesencephalic 6-hydroxydopamine injections. Brain Res 1991, 554:46-55.
32. Zhao J., Zhao Y., Zheng W., Lu Y., Feng G., Yu S. Neuroprotective effect of curcumin on transient focal cerebral ischemia in rats. Brain Res 2008, 1229:224-232.
33. Xue X., Qu X.J., Yang Y., Sheng X.H., Cheng F., Jiang E.N., et al. Baicalinattenuates focal cerebral ischemic reperfusion injury through inhibition of nuclear factor κB p65 activation. Biochem Biophys Res Commun 2010, 403:398-404.
34. Liszczak T.M., Hedley-Whyte E.T., Adams J.F., Han D.H., Kolluri V.S., Vacanti F.X., et al. Limitations of tetrazolium salts in delineating infarcted brain. Acta Neuropathol 1984, 65:150-157.
35. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986, 17:472-476.
36. Faraci F.M. Reactive oxygen species: influence on cerebral vascular tone. J Appl Physiol 2006, 100:739-743.
37. Mantha A.K., Moorthy K., Cowsik S.M., Baquer N.Z. Neuroprotective role of neurokinin B (NKB) on beta-amyloid (25-35) induced toxicity in aging rat brain synaptosomes: involvement in oxidative stress and excitotoxicity. Biogerontology 2006, 71:17.
38. Broughton B.R., Reutens D.C., Sobey C.G. Apoptotic mechanisms after cerebral ischemia. Stroke 2009, 40:331-339.
39. Ahmad A., Khan M.M., Hoda M.N., Raza S.S., Khan M.B., Javed H., et al. Quercetin protects against oxidative stress associated damages in a rat model of transient focal cerebral ischemia and reperfusion. Neurochem Res 2011, 36:1360-1371.
40. Chang C.Y., Ke D.S., Chen J.Y. Essential fatty acids and human brain. Acta Neurol Taiwan 2009, 18:231-241.
41. Ahmad M., Saleem S., Ahmad A.S., Yousuf S., Ansari M.N., Khan M.B., et al. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. J Neurochem 2005, 93:94-104.
42. Reed D.M. The paradox of high risk of stroke in populations with low risk of coronary heart disease. Am J Epidemiol 1990, 131:579-588.
43. Freeman B.A., Crapo J.D. Biology of disease: free radicals and tissue injury. Lab Invest 1982, 47:412-426.
44. Sharma M., Gupta Y.K. Effect of chronic treatment of melatonin on learning, memory and oxidative deficiencies induced by intracerebroventricularstreptozotocin in rats. Pharmacol Biochem Behav 2001, 70:325-331.
45. Kumar V.M.H., Gupta Y.K. Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats. Clin Exp Pharmacol Physiol 2003, 30:336-342.
46. Imam S.Z., Ali S.F. Selenium, an antioxidant, attenuates methamphetamine-induced dopaminergic toxicity and peroxynitrite generation. Brain Res 2000, 855:186-191.
47. Jungsook C.h.o. Antioxidant and neuroprotective effects of hesperidin and its aglyconehesperetin. Arch Pharm Res 2006, 29:699-706.
48. Basu A., Krady J.K., O'Malley M., Styren S.D., DeKosky S.T., Levison S.W. The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflammatory mediators in response to brain injury. J Neurosci 2002, 22:6071-6082.
49. Samdani A.F., Dawson T.M., Dawson V.L. Nitric oxide synthase in models of focal ischemia. Stroke 1997, 28:1283-1288.
50. Shen J., Zhang H., Lin H., Su H., Xing D., Du L. Brazilein protects the brain against focal cerebral ischemia reperfusion injury correlating to inflammatory response suppression. Eur J Pharmacol 2007, 558:88-95.
51. Danielisova V., Burda J., Nemethova M., Gottlieb M. Aminoguanidine administration ameliorates hippocampal damage after middle cerebral artery occlusion in rat. Neurochem Res 2011, 36:476-486.
52. Yamakawa H., Jezova M., Ando H., Saavedra J.M. Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition. J Cereb Blood Flow Metab 2003, 23:371-380.
53. Hsu Y.H., Hsu B.G., Chen H.I. Malignant alterations following early blockade of nitric oxide synthase in hypertensive rats. Chin J Physiol 2007, 50:283-293.